Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia
Journal of Clinical Oncology, 08/03/2012
Burnett AK et al. – Adding GO (3mg/m2) to induction chemotherapy reduces relapse risk and improves survival with little increase in toxicity.



